News

Boston Globe: The search for a pill that treats concussions

The search for a pill that treats concussions MICHAEL SWENSEN FOR THE BOSTON GLOBE William Korinek, CEO of Astrocyte Pharmaceuticals, played tag football in Mystic with his two sons and friends. By Jonathan Saltzman GLOBE STAFF  NOVEMBER 23, 2018 William Korinek loves professional football and, as a native Minnesotan who moved to New England in 1995, he roots […]

Read More »

Prevasol May Have a Bold Impact on Preventing CTE

Prevasol May Have A Bold Impact On Preventing CTE 21 November Over 1.7 million people in the U.S. are treated for concussions according to the Centers for Disease Control. This figure doesn’t include those with minor brain injuries who fail to seek medical attention. These statistics, combined with changing social perspectives on contact sports and […]

Read More »

Prevacus Announces Use of blinktbi’s EyeStat in Upcoming Phase 1 Clinical Study

Prevacus Announces Use of blinktbi’s EyeStat in Upcoming Phase 1 Clinical Study NEWS PROVIDED BY Prevacus, Inc. Jul 13, 2018, 07:30 ET TALLAHASSEE, Fla., July 13, 2018 /PRNewswire/ — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI) and other neurological disorders today announced a partnership with blinktbi, Inc for […]

Read More »

Can this Drug Save Football?

Brett Favre had a 20-year career in the NFL, including an iron-man stint in which he played in 321 straight games. But it was his last play in the league that was a painful exclamation point on his illustrious tenure. In December 2010, while playing for the Vikings, the quarterback was sacked and knocked out […]

Read More »

Prevacus Announces the Addition of Key Individuals to its Sports Advisory Board

TALLAHASSEE, Fla., Feb. 22, 2017 (GLOBE NEWSWIRE) — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced the addition of Steve Mariucci, Eddie DeBartolo Jr., Matt Hasselbeck and Warren Moon to its sports advisory board. “I am delighted to have the […]

Read More »

Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion

TALLAHASSEE, Fla., Feb. 09, 2017 (GLOBE NEWSWIRE) — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion aka mild Traumatic Brain Injury (mTBI) and other neurological disorders; today announced plans to initiate Phase 1 clinical studies of a novel treatment for concussion in humans. The Company expects to initiate its Phase 1 […]

Read More »

Dr. Jake VanLandingham: “It’s Time to Change the Way We Treat Concussions, Not the Game of Football.”

Tallahassee, FL – Dr. Jake VanLandingham, an expert in the field of neuroscience and Founder and President of Prevacus Inc., a Florida-based pharmaceutical company currently developing the first field-deliverable drug to treat concussions, said the new rule issued by the NCAA to protect athletes from concussions reiterates the importance of developing a treatment to the […]

Read More »